TR200000266T2 - Antimetastaz maddeler olarak faydalı oligo-tiofenler, bunların ve bunları ihtiva eden farmasötik bileşimlerin hazırlanması. - Google Patents
Antimetastaz maddeler olarak faydalı oligo-tiofenler, bunların ve bunları ihtiva eden farmasötik bileşimlerin hazırlanması.Info
- Publication number
- TR200000266T2 TR200000266T2 TR2000/00266T TR200000266T TR200000266T2 TR 200000266 T2 TR200000266 T2 TR 200000266T2 TR 2000/00266 T TR2000/00266 T TR 2000/00266T TR 200000266 T TR200000266 T TR 200000266T TR 200000266 T2 TR200000266 T2 TR 200000266T2
- Authority
- TR
- Turkey
- Prior art keywords
- antimetastases
- oligo
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 239000002257 antimetastatic agent Substances 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97113191 | 1997-07-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200000266T2 true TR200000266T2 (tr) | 2000-09-21 |
Family
ID=8227153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/00266T TR200000266T2 (tr) | 1997-07-31 | 1998-07-28 | Antimetastaz maddeler olarak faydalı oligo-tiofenler, bunların ve bunları ihtiva eden farmasötik bileşimlerin hazırlanması. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1000054A1 (fr) |
| JP (1) | JP2001512116A (fr) |
| KR (1) | KR20010022500A (fr) |
| CN (1) | CN1269797A (fr) |
| AR (1) | AR020308A1 (fr) |
| AU (1) | AU738104B2 (fr) |
| BR (1) | BR9811577A (fr) |
| CA (1) | CA2299045A1 (fr) |
| CO (1) | CO4970718A1 (fr) |
| HR (1) | HRP980420A2 (fr) |
| MA (1) | MA26527A1 (fr) |
| TR (1) | TR200000266T2 (fr) |
| WO (1) | WO1999006393A1 (fr) |
| ZA (1) | ZA986800B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19842416A1 (de) * | 1998-09-16 | 2000-04-13 | Max Planck Gesellschaft | Sekundäre Amine zur Prävention und Therapie von Erkrankungen, die durch Oxidationsprozesse verursacht oder verstärkt werden |
| AU2002358158A1 (en) * | 2001-12-19 | 2003-06-30 | D. Collen Research Foundation | Use of urokinase receptor antagonists to modulate ischemiareperfusion injury |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9410387D0 (en) * | 1994-05-24 | 1994-07-13 | Xenova Ltd | Pharmaceutical compounds |
-
1998
- 1998-07-28 CN CN98807766A patent/CN1269797A/zh active Pending
- 1998-07-28 CA CA002299045A patent/CA2299045A1/fr not_active Abandoned
- 1998-07-28 JP JP2000505151A patent/JP2001512116A/ja active Pending
- 1998-07-28 BR BR9811577-4A patent/BR9811577A/pt not_active IP Right Cessation
- 1998-07-28 KR KR1020007001086A patent/KR20010022500A/ko not_active Withdrawn
- 1998-07-28 WO PCT/EP1998/004705 patent/WO1999006393A1/fr not_active Ceased
- 1998-07-28 TR TR2000/00266T patent/TR200000266T2/xx unknown
- 1998-07-28 EP EP98939643A patent/EP1000054A1/fr not_active Withdrawn
- 1998-07-28 AU AU88079/98A patent/AU738104B2/en not_active Ceased
- 1998-07-29 CO CO98043237A patent/CO4970718A1/es unknown
- 1998-07-30 ZA ZA9806800A patent/ZA986800B/xx unknown
- 1998-07-30 HR HR97113191.7A patent/HRP980420A2/hr not_active Application Discontinuation
- 1998-07-30 AR ARP980103754A patent/AR020308A1/es not_active Application Discontinuation
- 1998-07-31 MA MA25199A patent/MA26527A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR020308A1 (es) | 2002-05-08 |
| EP1000054A1 (fr) | 2000-05-17 |
| JP2001512116A (ja) | 2001-08-21 |
| KR20010022500A (ko) | 2001-03-15 |
| CN1269797A (zh) | 2000-10-11 |
| AU738104B2 (en) | 2001-09-06 |
| BR9811577A (pt) | 2000-08-29 |
| ZA986800B (en) | 2000-01-31 |
| AU8807998A (en) | 1999-02-22 |
| MA26527A1 (fr) | 2004-12-20 |
| HRP980420A2 (en) | 1999-04-30 |
| CA2299045A1 (fr) | 1999-02-11 |
| WO1999006393A1 (fr) | 1999-02-11 |
| CO4970718A1 (es) | 2000-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE383169T1 (de) | Komponente und zusammensetzungen zur verabreichung von wirkstoffen | |
| TR200100005T2 (tr) | Çamaşır ve temizlik terkipleri. | |
| TR200001203T2 (tr) | Yeni birleşik maddeler | |
| ATE163042T1 (de) | Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung | |
| TR200001218T2 (tr) | İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler. | |
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| MX9203396A (es) | Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas. | |
| TR199800720T2 (xx) | Farnesil transferaz inhibe eden 2-kinolon t�revleri. | |
| RU94042922A (ru) | Новые соединения, способы их получения, фармацевтическая композиция | |
| ES2193337T3 (es) | Utilizacion de sales de estroncio para el tratamiento de la artrosis. | |
| PT1140944E (pt) | Derivados de epotilona e sua utilizacao como agentes antitumorais | |
| DK1000035T3 (da) | Substituerede 6-phenylphenanthridiner | |
| SE9802729D0 (sv) | Novel Compounds | |
| DE69709407D1 (de) | Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen | |
| ATE423562T1 (de) | Alpha-ketoamidhaltige multikatalytische protease inhibitoren | |
| ATE356608T1 (de) | Behandlung der multiplen sklerose durch einnahme von copolymer-1 | |
| PT902789E (pt) | Derivados de androsteno | |
| IL141157A0 (en) | Salt form of pantoprazole and pharmaceutical compositions containing the same | |
| DE69625354D1 (de) | Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen | |
| FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
| EA200201138A1 (ru) | Пептид, модулирующий рецептор тромбопоэтина | |
| DE69918972D1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
| AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
| TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
| ATE280588T1 (de) | Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren |